National Cancer Institute: Cancer Currents Blog

The National Cancer Institute (NCI) serves as the primary federal organization dedicated to cancer research.

Local

English

Blog

Outlet metrics

Domain Authority

Ranking

Global

#18584

United States

#8269

Health/Health Conditions and Concerns

#11

Traffic sources

Monthly visitors

Articles

CAR T Cells: Engineering Immune Cells to Treat Cancer - NCI

Feb 26, 2025 | cancer.gov

Research on CAR T-cell therapy is progressing rapidly to improve the cancer treatment, expand its use to more cancers, and better manage its side effects.
Helping Health Professionals Reduce Lung Cancer Stigma - NCI

Jan 15, 2025 | cancer.gov

Researchers have developed a training program to help health providers reduce lung cancer stigma and have launched a clinical trial to test the training.
2021 NCI Outstanding Investigator Award Recipients - NCI

Jan 13, 2025 | cancer.gov

Learn how these investigators' projects aim to break new ground in biomedical, behavioral, and clinical cancer research.
GD2 CAR T Cells Show Promise Against DMG - NCI

Jan 2, 2025 | cancer.gov

A CAR T-cell therapy that targets GD2 on cancer cells shrank tumors—sometimes for long periods—in children and young adults with diffuse midline gliomas.
Season 2 - Episode 15: AI and Immunotherapy: A Breakthrough in Cancer Treatment - NCI

Dec 27, 2024 | cancer.gov

Inside Cancer Careers Podcast AI and Immunotherapy: A Breakthrough in Cancer Treatment
One Year in Cancer Research and Much to Celebrate - NCI

Dec 20, 2024 | cancer.gov

NCI Director Dr. Kimryn Rathmell reviews some of the most noteworthy cancer research findings from 2024, including advances in immunotherapy for children with cancer, a potential therapy for cachexia, and valuable insights into cancer biology.
Black Patients’ Beliefs About Clinical Research - NCI

Nov 15, 2024 | cancer.gov

More Black patients than non-Black cancer patients hold spiritual beliefs about and have a mistrust of clinical research, a small study has found.
myeloMATCH will test tailored treatments for AML and MDS - NCI

Oct 24, 2024 | cancer.gov

NCI has launched myeloMATCH, a precision medicine treatment trial for people with acute myeloid leukemia and myelodysplastic syndromes.
Oncologists Struggle with Patients’ Questions About Cannabis - NCI

Oct 14, 2024 | cancer.gov

As more people with cancer use cannabis to help with symptoms and side effects, cancer care providers feel ill-equipped to discuss issues like safety.
Mammogram False Positives Affect Future Screening Behavior - NCI

Oct 5, 2024 | cancer.gov

Some women who receive a false-positive result on a mammogram may not come back for routine breast cancer screening in the future, a new study has found.